Vanguard Capital Management
QTTB icon

Vanguard Capital Management’s Q32 Bio QTTB Stock Holding History

Vanguard Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Buy
518,803
+212,402
+69% +$1.77M ﹤0.01% 3014
2026
Q1 		$1.97M Buy
+306,401
New +$1.46M ﹤0.01% 3369

Other funds holding QTTB

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Vanguard Capital Management's QTTB Position: Q2 2026 in Review

Vanguard Capital Management increased its Q32 Bio (QTTB) stake by 69% in Q2 2026, buying an estimated $1.77M and bringing the position to 518,803 shares worth $6.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

Vanguard Capital Management first reported a position in QTTB in Q1 2026 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

  • Vanguard Capital Management held 518,803 shares of Q32 Bio worth $6.61M as of Q2 2026.
  • Vanguard Capital Management bought 212,402 Q32 Bio shares in Q2 2026, an estimated $1.77M.
  • Q32 Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3014 holding.
  • Vanguard Capital Management first reported a position in Q32 Bio in Q1 2026 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.